Beginning in February 2015, Dr. Margaret (Peggy) Hamburg, MD will take up her new post as the President of the American Association for the Advancement of Science (AAAS). She is currently a board member of the Parker Institute for Cancer Immunotherapy and the foreign secretary of the National Academy of Medicine (NAM). She will continue in these roles as she also serves at the President of the AAAS. Dr. Hamburg graduated from Harvard College and then earned her medical degree from Harvard Medical school. She is board certified in Internal Medicine.

Dr. Hamburg stated that this is a very exciting time for science. She believes that the opportunities in the medical community are enormous and that the entire medical community needs to work together to be certain that medical and scientific discoveries continue. These discoveries need to be taken as soon and efficiently as possible into products and interventions that will make a difference in the lives of their patients. She believes that support needs to be given to the education and advocacy that science must play in our future and current lives.

Before her current positions, Dr. Hamburg was the commissioner of the US Food and Drug Administration (FDA). She served in that position for 6 years under President Obama. During her tenure at the FDA, she worked on the advancement of regulatory science and encouraged medical product innovation. She also helped develop laws to increase food safety and help curb the use of tobacco in American citizens. Before she joined the FDA, she was a senior scientist and Vice President of the Nuclear Threat Initiative. Under President Bill Clinton, she served as the assistant secretary for planning and evaluation at the US Department of Health and Services. She has an extensive background, knowledge, and experience to bring to her new position. She has spent her career gaining extensive knowledge and experience in healthcare, science, and regulations that will help the AAAS continue to excel and innovate the boundaries of cancer immunotherapy research. Her leadership will bring a fresh vision, strategic direction, and knowledgeable guidance to the AAAS.